Percutaneous coronary intervention vascular closure devices

Revision as of 14:57, 19 October 2012 by Shankar Kumar (talk | contribs) (Created page with "__NOTOC__ {{Percutaneous Coronary Intervention}} {{CMG}} ==ACCF/AHA/SCAI 2011 Guidelines for Percutaneous Coronary Intervention: Vascular Closure Devices<ref name="pmid220708...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Percutaneous Coronary Intervention Guidelines Microchapters

Home

Patient Information

Overview

PCI Approaches:

CAD Revascularization:

Heart Team Approach to Revascularization Decisions
Left Main Coronary Artery Disease
Intervention in left main coronary artery disease
Non-Left Main Coronary Artery Disease
Revascularization to Improve Symptoms
Dual Antiplatelet Therapy Compliance and Stent Thrombosis
Hybrid Coronary Revascularization

Pre-procedural Considerations:

Contrast-Induced Acute Kidney Injury
Anaphylactoid Reactions
Statin Treatment
Bleeding Risk
Role of Onsite Surgical Backup

Procedural Considerations:

Vascular Access
PCI in Specific Clinical Situations:
Asymptomatic Ischemia or CCS Class I or II Angina
CCS Class III Angina
Unstable Angina/Non–ST-Elevation Myocardial Infarction
ST-Elevation Myocardial Infarction:
General and Specific Considerations
Coronary Angiography Strategies in STEMI
Primary PCI of the Infarct Artery
Delayed or Elective PCI in patients with STEMI
Fibrinolytic-Ineligible Patients
Facilitated PCI
Rescue PCI
After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion
Cardiogenic Shock
Prior Coronary Bypass Surgery
Revascularization Before Non-cardiac Surgery
Adjunctive Diagnostic Devices:
Fractional Flow Reserve
Intravascular Ultrasound
Adjunctive Therapeutic Devices:
Coronary Atherectomy
Thrombectomy
Laser Angioplasty
Cutting Balloon Angioplasty
Embolic Protection Devices
Percutaneous Hemodynamic Support Devices
Antiplatelet therapy:
Oral Antiplatelet Therapy
Glycoprotein IIb/IIIa Receptor Antagonists
Intravenous Antiplatelet therapy:
STEMI
UA/NSTEMI
SIHD
Anticoagulant Therapy:
Parenteral Anticoagulants During PCI
Unfractionated Heparin
Enoxaparin
Bivalirudin and Argatroban
Fondaparinux
No-Reflow Pharmacological Therapies
PCI in Specific Anatomic Situations:
Chronic Total Occlusions
Saphenous Vein Grafts
Bifurcation Lesions
Aorto-Ostial Stenoses
Calcified Lesions
PCI in Specific Patient Populations:
Chronic Kidney Disease
Peri-procedural Myocardial Infarction Assessment
Vascular Closure Devices

Post-Procedural Considerations:

Post-procedural Antiplatelet Therapy
Proton Pump Inhibitors and Antiplatelet Therapy
Clopidogrel Genetic Testing
Platelet Function Testing
Restenosis
Exercise Testing
Cardiac Rehabilitation

Quality and Performance Considerations:

Quality and Performance
Certification and Maintenance of Certification
Operator and Institutional Competency and Volume

Percutaneous coronary intervention vascular closure devices On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Percutaneous coronary intervention vascular closure devices

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Percutaneous coronary intervention vascular closure devices

CDC on Percutaneous coronary intervention vascular closure devices

Percutaneous coronary intervention vascular closure devices in the news

Blogs on Percutaneous coronary intervention vascular closure devices

Directions to Hospitals Treating Percutaneous Coronary Intervention

Risk calculators and risk factors for Percutaneous coronary intervention vascular closure devices

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

ACCF/AHA/SCAI 2011 Guidelines for Percutaneous Coronary Intervention: Vascular Closure Devices[1] (DO NOT EDIT)

Class I
"1. Patients considered for vascular closure devices should undergo a femoral angiogram to ensure their anatomic suitability for deployment. (Level of Evidence: C)"
Class III (No Benefit)
"1. The routine use of vascular closure devices is not recommended for the purpose of decreasing vascular complications, including bleeding.[2][3][4][5][6][7] (Level of Evidence: B)"
Class IIa
"1. The use of vascular closure devices is reasonable for the purposes of achieving faster hemostasis and earlier ambulation compared with the use of manual compression.[2][3][4][5] (Level of Evidence: B)"

References

  1. ↑ Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH (2011). "2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions" (PDF). Journal of the American College of Cardiology. 58 (24): 2550–83. doi:10.1016/j.jacc.2011.08.006. PMID 22070837. Retrieved 2011-12-08. Text "PDF" ignored (help); Unknown parameter |month= ignored (help)
  2. ↑ 2.0 2.1 Biancari F, D'Andrea V, Di Marco C, Savino G, Tiozzo V, Catania A (2010). "Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty". American Heart Journal. 159 (4): 518–31. doi:10.1016/j.ahj.2009.12.027. PMID 20362708. Retrieved 2011-12-16. Unknown parameter |month= ignored (help)
  3. ↑ 3.0 3.1 Dauerman HL, Applegate RJ, Cohen DJ (2007). "Vascular closure devices: the second decade". Journal of the American College of Cardiology. 50 (17): 1617–26. doi:10.1016/j.jacc.2007.07.028. PMID 17950141. Retrieved 2011-12-16. Unknown parameter |month= ignored (help)
  4. ↑ 4.0 4.1 Koreny M, Riedmüller E, Nikfardjam M, Siostrzonek P, Müllner M (2004). "Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis". JAMA : the Journal of the American Medical Association. 291 (3): 350–7. doi:10.1001/jama.291.3.350. PMID 14734598. Retrieved 2011-12-16. Unknown parameter |month= ignored (help)
  5. ↑ 5.0 5.1 Patel MR, Jneid H, Derdeyn CP, Klein LW, Levine GN, Lookstein RA, White CJ, Yeghiazarians Y, Rosenfield K (2010). "Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association". Circulation. 122 (18): 1882–93. doi:10.1161/CIR.0b013e3181f9b345. PMID 20921445. Retrieved 2011-12-16. Unknown parameter |month= ignored (help)
  6. ↑ Hoffer EK, Bloch RD (2003). "Percutaneous arterial closure devices". Journal of Vascular and Interventional Radiology : JVIR. 14 (7): 865–85. PMID 12847195. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  7. ↑ Nikolsky E, Mehran R, Halkin A, Aymong ED, Mintz GS, Lasic Z, Negoita M, Fahy M, Krieger S, Moussa I, Moses JW, Stone GW, Leon MB, Pocock SJ, Dangas G (2004). "Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis". Journal of the American College of Cardiology. 44 (6): 1200–9. doi:10.1016/j.jacc.2004.06.048. PMID 15364320. Retrieved 2011-12-16. Unknown parameter |month= ignored (help)

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Percutaneous_coronary_intervention_vascular_closure_devices&oldid=777833"